T. Otto
Impact in
Papers in
- Surgery 107
- Bladder and Urothelial Cancer Treatments 82
- Hernia repair and management 10
-
- Renal cell carcinoma treatment 15
- Prostate Cancer Treatment and Research 12
- Prostate Cancer Diagnosis and Treatment 7
- Co-authors
- Herbert Rubben (61 shared papers)Holger Gerullis (44 shared papers)S. Krege (21 shared papers)Gerd Lümmen (18 shared papers)Dimitri Barski (28 shared papers)Herbert V. Sperling (7 shared papers)Thorsten Ecke (31 shared papers)Μ. Goepel (22 shared papers)
- Journals
- The Journal of Urology (10 papers)European Urology (9 papers)International Journal of Molecular Sciences (6 papers)Urology (6 papers)Anti-Cancer Drugs (5 papers)
- Partner nations
- GermanyHungaryUnited States
In The Last Decade
T. Otto
158 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 104
- Urology 180
- Surgery 1k
- Rheumatology 214
- Oncology 301
- Pulmonary and Respiratory Medicine 350
Countries citing papers authored by T. Otto
This map shows the geographic impact of T. Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Otto more than expected).
Fields of papers citing papers by T. Otto
This network shows the impact of papers produced by T. Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Otto. The network helps show where T. Otto may publish in the future.
Co-authors
The 25 scholars most cited alongside T. Otto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 184 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 217 | |
| 2 | 1996 | 152 | |
| 3 | Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas. | 1994 | 122 |
| 4 | 1998 | 113 | |
| 5 | 1996 | 94 | |
| 6 | 2001 | 89 | |
| 7 | 1996 | 79 | |
| 8 | 1993 | 63 | |
| 9 | 2001 | 60 | |
| 10 | Systematic review and classification of complications after anterior, posterior, apical, and total vaginal mesh implantation for prolapse repair. | 2014 | 58 |
| 11 | 1997 | 52 | |
| 12 | 2011 | 48 | |
| 13 | 2010 | 42 | |
| 14 | 2012 | 41 | |
| 15 | Improved prognosis assessment for patients with bladder carcinoma. | 1997 | 40 |
| 16 | 2014 | 39 | |
| 17 | 2010 | 36 | |
| 18 | 2012 | 36 | |
| 19 | 2023 | 35 | |
| 20 | 1997 | 34 |
About T. Otto
T. Otto is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Rheumatology, Urology and Obstetrics and Gynecology, having authored 184 papers that have together received 2.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (82 papers), Pelvic floor disorders treatments (17 papers), Renal cell carcinoma treatment (15 papers), Prostate Cancer Treatment and Research (12 papers), Hernia repair and management (10 papers), Urinary Bladder and Prostate Research (8 papers), Genetic Associations and Epidemiology (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). The work is most often cited by research in Urology (180 citations), Surgery (1k citations), Rheumatology (214 citations), Oncology (301 citations) and Pulmonary and Respiratory Medicine (350 citations). T. Otto has collaborated with scholars based in Germany, Hungary and United States. Frequent co-authors include Herbert Rubben, Holger Gerullis, S. Krege, Gerd Lümmen, Dimitri Barski, Herbert V. Sperling, Thorsten Ecke, Μ. Goepel, Hans‐Joachim Luboldt and G. Giani. Their work appears in journals such as The Journal of Urology, European Urology, International Journal of Molecular Sciences, Urology and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.